Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Share News (HLN)

Share Price Information for Haleon (HLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.60
Bid: 323.00
Ask: 323.10
Change: 0.00 (0.00%)
Spread: 0.10 (0.031%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 322.60
HLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Retailers suffer as UK earnings lag inflation

Tue, 19th Jul 2022 08:39

(Alliance News) - Furniture seller Made.com on Tuesday lowered guidance as UK consumers rein in spending and warned that it may need to raise additional financing.

The warning from the retailer came as official figures showed UK earnings rising at only half the rate of inflation.

Made.com said gross sales in the first half of 2022 were down 19% year-on-year, though up 55% from pre-virus levels.

"Recent trading has been volatile, and the worsening of consumer confidence has impacted demand for discretionary big-ticket items, making new customer acquisition at financially attractive rates challenging," Made.com cautioned.

Profit for 2022 will take a GBP20 million one-off hit from clearance work related to excess inventory and additional costs in its supply chain.

For 2022, Made now expects gross sales to fall by between 15% to 30%. It had previously expected an outcome ranging from flat sales to a 15% fall.

Revenue guidance has been lowered to a range of a 9% fall to a 24% fall from between 8% growth and a 7% decline previously.

Made said it is considering options to strength its balance sheet, as it lowered its 2022 year-end cash forecast to between GBP5 million and GBP30 million from between GBP40 million and GBP65 million previously.

Made.com shares were down 37% early Tuesday at 24.15p.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.6% at 7,183.32

----------

Hang Seng: down 0.8% at 20,680.43

Nikkei 225: closed up 0.7% at 26,961.68

S&P/ASX 200: closed down 0.6% at 6,649.60

----------

DJIA: closed down 215.65 points, or 0.7%, at 31,072.61

S&P 500: closed down 32.31 points, or 0.8%, at 3,830.85

Nasdaq Composite: closed down 92.37 points, or 0.8%, at 11,360.05

----------

EUR: flat at USD1.0164 (USD1.0167)

GBP: soft at USD1.1970 (USD1.1994)

USD: lower at JPY137.74 (JPY138.17)

GOLD: lower at USD1,708.91 per ounce (USD1,709.33)

OIL (Brent): higher at USD106.29 a barrel (USD105.55)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Tuesday's key economic events still to come

1000 CEST EU ECB bank lending survey

1100 CEST EU harmonised consumer price index

1100 CEST EU construction output

0830 EDT US new residential construction

1630 EDT US API weekly statistical bulletin

0855 EDT US Johnson Redbook retail sales index

----------

The UK unemployment rate remained unchanged in the three months to May, in line with market expectations. The jobless rate was 3.8%, the same level as in the three months in April, according to the Office for National Statistics. A year earlier, the unemployment rate had sat at 4.9%. The latest figure was in line with FXStreet cited consensus.

----------

UK wage growth figures, meanwhile, showed average earnings including bonuses rose 6.2% on an annual basis, slowing from 6.8% in the reading for April and below FXStreet-cited consensus of 6.9%. Excluding bonuses, wages grew 4.3%, in line with consensus and picking up from 4.2% growth in April. That means UK earnings by both measures continue to lag consumer price inflation, which ran at 9.1% in May.

----------

BROKER RATING CHANGES

----------

Barclays starts Haleon with 'equal weight' - price target 348 pence

----------

Oddo BHF starts Vodafone with 'neutral' - price target 140 pence

----------

JPMorgan places Segro on 'positive catalyst watch'

----------

COMPANIES - FTSE 100

----------

Business publisher and events organiser Informa backed annual expectations. Informa still expects revenue between GBP2.15 billion to GBP2.25 billion for 2022, with adjusted operating profit between GBP470 million to GBP490 million. At best, this would represent revenue growth of 25% from GBP1.80 billion in 2021 and adjusted operating profit growth of 26% from GBP388.4 million. Guidance does not include any contribution from Industry Dive, which Informa announced it has acquired for up to USD525 million. The initial cash consideration is USD389 million. "Industry Dive brings a scalable, single proprietary technology platform, which will enable us to expand our digital services capabilities and deliver content led services to our B2B audiences," Informa said. Informa said that for the first half of 2022, it expects to report underlying revenue growth of 40%, helped by a return of live events.

----------

COMPANIES - FTSE 250

----------

Cybersecurity company Darktrace said it expects revenue growth of 48% in the financial fourth quarter that ended June 30. It forecasts an annualised recurring revenue climb of 42%. "Darktrace continued to deliver strong sales performance in its fourth quarter, adding over 500 net new customers, and bringing the group's customer base at year-end to over 7,400. This reflects year-over-year growth of approximately 32%," the company said. For the year, Darktrace expects revenue of USD417.0 million, up 48%. Its adjusted earnings before interest, tax, depreciation and amortisation margin is tipped to land at 19.5%, above its previous guidance range of 15% to 17%. For the new financial year, revenue growth will slow. Darktrace expects a revenue rise of between 29% and 32%. Growth has been hit by foreign currency movements. "It cautions that particularly for the first six-to-nine months of the year, year-over-year growth comparisons are expected to be dampened by the impact that significant movements in exchange rates relative to the prior year period have already had, and are expected to continue to have, on the conversion of British pound and euro-denominated ARR to US dollar-denominated revenue," Darktrace explained.

----------

COMPANIES - SMALL CAP

----------

Wise has kicked off its new financial year with growth in revenue and volumes. In the three months ended June, the international money transfer service provider said revenue grew 51% yearly to GBP185.9 million from GBP123.5 million. Quarter-on-quarter, revenue was up 21%. Transaction volumes were 49% higher yearly and 14% higher quarterly at GBP24.4 billion. "Volume growth was driven by a higher number of active customers that are increasingly using the Wise Account and Wise Business products, which in turn also leads to a higher average volume per customer. The growth also reflects to a lesser extent, more variable drivers which include people and businesses responding to increased levels of FX volatility and the translation impact from FX movements which was a tailwind in the quarter, compared with a headwind in FY22. On a constant currency basis volume grew 45% year-on-year," Wise explained. Wise left revenue guidance unchanged. It still expects annual growth of between 30% and 35% for financial 2023.

----------

COMPANIES - GLOBAL

----------

Novartis reported a drop in second-quarter income and a fall in sales but nonetheless reconfirmed its guidance for 2022 as a whole. The Basel, Switzerland-based pharmaceutical company posted net income of USD1.70 billion in the second quarter of 2022, representing a 36% drop against the previous year's figure of USD2.65 billion. Earnings per share fell by a similar percentage, dropping 36% to USD0.77 per share from USD1.19 the previous year. Net sales declined more modestly, slipping 1.4% to USD12.78 billion from USD12.96 billion. The firm explained that price erosion and competition from generic drugs was the reason behind the drop in sales. In contrast, key sales drivers were arthritis and psoriasis drug Cosentyx, heart failure treatment Entresto, spinal muscular atrophy drug Zolgensma, breast cancer drug Kisqali, multiple sclerosis therapy Kesimpta, and cholesterol drug Leqvio - all of which grew in double digits, Novartis added.

----------

Tuesday's shareholder meetings

Biotech Growth Trust PLC - AGM

Clean Power Hydrogen PLC - AGM

e-Therapeutics PLC - AGM

Norcros PLC - AGM

Ten Lifestyle Group PLC - GE re commitment to sustainability, B Corp certification

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
23 Jun 2023 08:52

LONDON MARKET OPEN: Stocks down after BoE; GSK up on Zantac settlement

(Alliance News) - Stock prices in London opened lower on Friday, as rising interest rates weighed on housebuilding stocks in the FTSE 100.

Read more
23 Jun 2023 08:23

TOP NEWS: GSK reaches settlement in California Zantac lawsuit

(Alliance News) - GSK PLC on Friday said a Zantac trial set to begin next month in California has been dismissed after it reached a confidential settlement.

Read more
8 Jun 2023 12:09

London "still attractive" place to list, as IPO activity trickles back

(Alliance News) - A recent revival of initial public offerings in London's equity markets is encouraging evidence that the city still holds appeal on the global stage, analysts contended.

Read more
6 Jun 2023 07:41

PRESS: Unilever starts search to replace Nils Andersen as chair

(Alliance News) - Unilever PLC has appointed executive search firm Spencer Stuart to find a replacement for Chair Nils Andersen, Bloomberg reported on Monday, citing "people familiar with the situation".

Read more
12 May 2023 08:26

TOP NEWS: GSK welcomes legal ruling in Canada; sells Haleon shares

(Alliance News) - GSK PLC on Friday welcomed a legal ruling in Canada that threw out a proposed class action made on behalf of users of a heartburn drug.

Read more
12 May 2023 07:52

GSK sells 2.4% of Haleon stake via placing for £804m

(Sharecast News) - UK pharmaceuticals company GSK said it had sold a 2.5% stake in Haleon at 335p a share, raising £804m.

Read more
12 May 2023 07:50

LONDON BRIEFING: No Apollo offer for THG; GSK trims Haleon stake

(Alliance News) - Stocks in London were called to open higher on Friday, after data showed the UK economy expanded 0.1% over the first three months of the year.

Read more
11 May 2023 09:45

LONDON BROKER RATINGS: Asos targets cut; Jefferies ups Diploma to buy

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
9 May 2023 09:29

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning:

Read more
4 May 2023 09:31

LONDON BROKER RATINGS: Wells Fargo cuts Flutter; Shore says 'sell' CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
3 May 2023 16:58

LONDON MARKET CLOSE: FTSE 100 in the green ahead of Fed rate decision

(Alliance News) - Stocks in London were higher at the close on Wednesday as investor waited with bated breath for the US Federal Reserve's next interest rate decision.

Read more
3 May 2023 11:20

PRESS: Pfizer to begin selling Haleon interest within months - FT

(Alliance News) - Pfizer Inc will begin offloading its 32% stake in Haleon PLC as it focuses on reducing debt linked to its USD43 billion acquisition of Seagen Inc and boosting returns to shareholders, according to the Financial Times.

Read more
3 May 2023 09:12

TOP NEWS: Haleon reports quarterly double-digit revenue growth

(Alliance News) - Haleon PLC on Wednesday said strong performance across all categories and regions drove its quarterly growth.

Read more
3 May 2023 09:11

LONDON MARKET OPEN: Dollar softens ahead of US rate announcement

(Alliance News) - Stock prices in London opened in the green on Wednesday, as investors await what is anticipated to be the final interest rate hike from the US Federal Reserve this tightening cycle.

Read more
3 May 2023 07:18

Haleon profits rise but margins squeezed by cost inflation

(Sharecast News) - Profits at consumer health company Haleon on Wednesday came in below expectations as higher costs hit earnings margins.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.